The Food and Drug Administration has approved a new drug to treat advanced pancreatic cancer. This breakthrough could potentially extend the survival of patients with metastatic pancreatic cancer. The approval was announced on Wednesday, marking a significant development for those affected by this type of cancer.

Further information about the drug and its potential impact is available from the source, providing more details on this medical advancement.